MAHON PAUL A — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

MAHON PAUL A has filed 5 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $108.23M.

Profile

Paul A. Mahon serves as the Executive Vice President and General Counsel at United Therapeutics Corp, where he has been involved in legal and compliance matters related to the company's operations. He has a significant role in overseeing legal affairs in the biopharmaceutical sector.

Board memberships

• United Therapeutics Corp

Awards & honors

• Overseeing legal affairs at United Therapeutics
• Contributing to drug development compliance
• Participating in SEC filings

Recent Transactions

Companies — Last 90 Days

• UNITED THERAPEUTICS Corp (UTHR) — 5 filings, last 2026-07-02

Frequently Asked Questions

Who is MAHON PAUL A?

Paul A. Mahon serves as the Executive Vice President and General Counsel at United Therapeutics Corp, where he has been involved in legal and compliance matters related to the company's operations. He has a significant role in overseeing legal affairs in the biopharmaceutical sector.…

How many SEC Form 4 filings has MAHON PAUL A submitted recently?

5 primary Form 4 filings in the last 90 days, covering 1 company.

Has MAHON PAUL A been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 192 open-market sales ($108.23M) across all tracked filings.

Where can I see all of MAHON PAUL A's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week